-
subscribe to RSS
Subscribe to the RSS for the latest breaking news.
Research Identifies Co-Infection That Complicates TB Treatment
Tuberculosis (TB) is a major threat to global health, with its greatest impact in poorly resourced areas, where patients are frequently co infected with TB and other infectious diseases.[more]
Vaccines generally safe, National Academy of Sciences says
The safety of vaccines has become the subject of intense debate in the United States and elsewhere in recent years.[more]
Risk Factors for Tuberculosis After Highly Active Antiretroviral Therapy Initiation in the United States and Canada: Implications for Tuberculosis Screening
Research conducted in Africa has identified the occurrence of a high incidence of TB in patients shortly after the initiation of ARVs. [more]
Association between use of HMG CoA Reductase inhibitors and mortality in HIV-infected patients
An observational study conducted at Johns Hopkins, which included 1538 patients who received their HIV care between 1998 and 2009 has shown that treatment with HMG-coenzyme A reductase inhibitors (statins) significantly reduces the risk of death for patients taking ARVs[more]
Set a bug to kill a bug
Engineered bacteria that can detect and kill human pathogens could provide a new way to treat antibiotic-resistant bacteria.[more]
A replicating Cytomegalovirus-based vaccine encoding a single Ebola Virus Nucleoprotein CTL Epitope confers protection against Ebola Virus
Human outbreaks of haemorrhagic disease caused by Ebola virus (EBOV) are a serious health concern in Central Africa.[more]
B Cell repertoire analysis identifies new antigenic domains on Glycoprotein B of Human CMV, the target of neutralizing antibodies
Human cytomegalovirus (HCMV), a herpesvirus, is a commonly encountered pathogen that causes severe disease in immunosuppressed patients and infected newborns.[more]
